Skip to main content
SpringerLink
Log in

Peritoneal Carcinomatosis: Drugs and Diseases

  • Book
  • © 1996

Overview

Editors:
  1. Paul H. Sugarbaker

    1. Washington Cancer Institute, Washington Hospital Center, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Cancer Treatment and Research (CTAR, volume 81)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 chapters)

  1. Front Matter

    Pages i-xvi
    Download chapter PDF

  2. Pharmacology

    1. Intraperitoneal taxol

      • Maurie Markman
      Pages 1-5

    2. Early postoperative intraperitoneal Adriamycin as an adjuvant treatment for visceral and retroperitoneal sarcoma

      • Paul H. Sugarbaker
      Pages 7-14

    3. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis

      • Arvil D. Stephens, James F. Belliveau, Paul H. Sugarbaker
      Pages 15-30

    4. Intraperitoneal regional chemotherapy with mitroxantrone

      • Karl H. Link, G. Hepp, L. Staib, U. Butzer, W. Böhm, H. G. Beger
      Pages 31-40

    5. Treatment of peritoneal carcinomatosis by continuous hyperthermic peritoneal perfusion with cisplatin

      • H. Richard Alexander, Douglas L. Fraker
      Pages 41-50

    6. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C

      • Vicente Fernández-Trigo, O. Anthony Stuart, Arvil D. Stephens, Louis D. Hoover, Paul H. Sugarbaker
      Pages 51-61

  3. Disease States

    1. Pathobiology of peritoneal carcinomatosis from ovarian malignancy

      • Tessa A. Sugarbaker, David Chang, Patricia Koslowe, Paul H. Sugarbaker
      Pages 63-74

    2. Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer

      • Paul H. Sugarbaker
      Pages 75-87

    3. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy

      • Paul H. Sugarbaker, David Chang, Patricia Koslowe
      Pages 89-104

    4. Pseudomyxoma peritonei

      • Paul H. Sugarbaker
      Pages 105-119

    5. Clinical determinants of treatment failure in patients with pseudomyxoma peritonei

      • Paul H. Sugarbaker, Vicente Fernández-Trigo, Falah Shamsa
      Pages 121-132

    6. Recurrent intraabdominal cancer causing intestinal obstruction: Washington Hospital Center experience with 42 patients managed by surgery and intraperitoneal chemotherapy

      • Andrew M. Averbach, Paul H. Sugarbaker
      Pages 133-147

    7. Peritoneal carcinomatosis: Natural history and rational therapeutic interventions using intraperitoneal chemotherapy

      • Paul H. Sugarbaker
      Pages 149-168

    8. Survival time and prevention of side effects of intraperitoneal hyperthermic perfusion with mitomycin C combined with surgery for patients with advanced gastric cancer

      • Shigeru Fujimoto, Makoto Takahashi, Takaaki Mutou, Kokuriki Kobayashi, Tadashi Toyosawa, Kimikazu Kondoh et al.
      Pages 169-176

    9. Intraperitoneal 5-fluorouracil and mitomycin C as adjuvants to resectable gastric cancer: A status report

      • Wansik Yu
      Pages 177-183

    10. Mechanism and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to carbon particles

      • Toshio Takahashi, Masataka Shimotsuma, Akeo Hagiwara, Toshiharu Yamaguchi
      Pages 185-192

    11. Peritoneal mesothelioma: Treatment approach based on natural history

      • Andrew M. Averbach, Paul H. Sugarbaker
      Pages 193-211

    12. Pathology of peritoneal mesothelioma

      • Mary E. Kass
      Pages 213-225

    13. Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas

      • Stephen E. Ettinghausen, Andrew M. Averbach
      Pages 227-237
Back to top

Keywords

About this book

Peritoneal carcinomatosis dominates the clinical picture of many patients with gastrointestinal, gynecological and urological cancers. For many of them its dev­ astating effects contribute directly to their death. Most clinicians consider peritoneal carcinomatosis an incurable metastatic disease and give palliative treatment, re­ stricted to limited surgery and systemic chemotherapy. Contrary to this view, Paul Sugarbaker and his collegues base their approach on the concept that peritoneal carcinomatosis represents regional tumor spread, similar in its impact on treatment and prognosis to that of lymph node metastases in other malignancies. This concept emphasises the value of regional tumor control, as a potentially curative measure. In this book the combination of aggressive cytoreduction and intraperitoneal chemotherapy to control peritoneal carcinomatosis is extensively explored. Basic to this approach is the observation that most cancer cells show only relative resistence against commonly available drugs, which can be overcome by a sufficient increase of drug concentrations in tumor tissue. After intraperitoneal delivery, drugs will reach high tissue concentrations in the superficial few cell layers, while plasma concentrations will remain below toxic levels. Patients with only limited residual tumor at the peritoneal surface after cytoreduction may therefore benefit from intraperitoneal chemotherapy.

Editors and Affiliations

  • Washington Cancer Institute, Washington Hospital Center, USA

    Paul H. Sugarbaker

Bibliographic Information

  • Book Title: Peritoneal Carcinomatosis: Drugs and Diseases

  • Editors: Paul H. Sugarbaker

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-1-4613-1245-1

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Kluwer Academic Publishers 1996

  • Hardcover ISBN: 978-0-7923-3726-3Published: 29 February 1996

  • Softcover ISBN: 978-1-4612-8530-4Published: 16 September 2011

  • eBook ISBN: 978-1-4613-1245-1Published: 06 December 2012

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: 288

  • Topics: Oncology, Cancer Research

Publish with us

Policies and ethics

Back to top

Search

Navigation